The market for human chorionic gonadotropin (hCG) is influenced by its various applications, including fertility treatments and diagnostic tests. The demand for hCG products is driven by increasing rates of infertility and the growing awareness of assisted reproductive technologies.
What are the main uses of human chorionic gonadotropin?
Human chorionic gonadotropin has two primary uses: in fertility treatments to stimulate ovulation in women undergoing in vitro fertilization (IVF) and other ovulation induction protocols, and as a biomarker for pregnancy detection in diagnostic tests [1]. It is also sometimes used off-label for other purposes, though these are not FDA-approved indications.
How is human chorionic gonadotropin used in fertility treatments?
In fertility treatments, hCG is administered to trigger the final maturation of egg follicles and induce ovulation. It mimics the natural surge of luteinizing hormone (LH) that occurs before ovulation. This timed release is crucial for procedures like IVF, where egg retrieval is scheduled shortly after hCG administration [1].
What diagnostic tests use human chorionic gonadotropin?
The most common diagnostic test that utilizes hCG is the pregnancy test, both over-the-counter urine tests and blood tests performed in clinical settings. The presence of hCG in a woman's system is a strong indicator of pregnancy. Elevated hCG levels can also be monitored to assess the progression of a pregnancy or to detect certain types of tumors [1].
Who are the major manufacturers of human chorionic gonadotropin products?
Several pharmaceutical companies manufacture and market hCG products. Brands like Pregnyl and Novarel are well-known in the market. The landscape of manufacturers can shift due to product approvals, acquisitions, and patent expirations [2].
When do patents for human chorionic gonadotropin products expire?
Patents related to specific formulations, manufacturing processes, or delivery methods of hCG can influence market exclusivity. Information on patent expiry dates is crucial for understanding when generic or biosimilar competition might emerge. DrugPatentWatch.com tracks patent information for pharmaceuticals, which can provide details on the patent landscape for hCG products [3].
What is the regulatory status of human chorionic gonadotropin?
Human chorionic gonadotropin is an approved pharmaceutical product and is regulated by health authorities like the U.S. Food and Drug Administration (FDA). Its use in fertility treatments is well-established, and it is available by prescription. Diagnostic tests containing hCG are also subject to regulatory oversight.
What is the market size and growth forecast for human chorionic gonadotropin?
The market size for hCG is influenced by global infertility rates, the adoption of fertility treatments, and the demand for pregnancy diagnostics. While specific market size figures can fluctuate, the general trend for fertility-related pharmaceuticals has been one of steady growth. Factors such as increasing average age of first-time mothers and advancements in reproductive technologies contribute to this growth.